MedPath

Samsung Medical Center

Samsung Medical Center logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1994-01-01
Employees
501
Market Cap
-
Website
http://www.samsunghospital.com

Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney Transplantation

Not Applicable
Completed
Conditions
Kidney Transplantation
Interventions
Procedure: Fluid loading
First Posted Date
2015-06-02
Last Posted Date
2015-06-02
Lead Sponsor
Samsung Medical Center
Target Recruit Count
42
Registration Number
NCT02459470
Locations
🇰🇷

Samsung Seoul Hospital, Samsung Medical Center, Seoul, Korea, Republic of

Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis

Phase 4
Conditions
Stroke
Intracranial Atherosclerosis
First Posted Date
2015-06-01
Last Posted Date
2017-04-26
Lead Sponsor
Samsung Medical Center
Target Recruit Count
80
Registration Number
NCT02458755
Locations
🇰🇷

Oh Young Bang, Seoul, Korea, Republic of

Pulse Pressure Variation Measured During Valsalva Maneuver to Predict Fluid Responsiveness Under Open-chest Condition

Completed
Conditions
Sternotomy
Thoracic Surgical Procedures
Cardiac Surgical Procedures
Interventions
Procedure: Valsalva maneuver
Other: Fluid loading
First Posted Date
2015-05-29
Last Posted Date
2015-09-14
Lead Sponsor
Samsung Medical Center
Target Recruit Count
55
Registration Number
NCT02457572
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy

Phase 2
Completed
Conditions
Advanced Gastric Cancer
Interventions
First Posted Date
2015-05-22
Last Posted Date
2019-12-30
Lead Sponsor
Samsung Medical Center
Target Recruit Count
21
Registration Number
NCT02451956
Locations
🇰🇷

Samsung Medical Center, Seoul, Seoul, Korea, Republic Of, Korea, Republic of

Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors

Not Applicable
Completed
Conditions
Refractory Solid Tumors
Interventions
First Posted Date
2015-05-21
Last Posted Date
2022-06-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
1
Registration Number
NCT02450123
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors

Not Applicable
Completed
Conditions
Refractory Solid Tumors
Interventions
First Posted Date
2015-05-21
Last Posted Date
2022-06-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
2
Registration Number
NCT02450136
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Lateral Rectus Muscle and Anterior Segment Optical Coherence Tomography (AS-OCT) in Two Recession Surgeries

Conditions
Intermittent Exotropia
Interventions
Procedure: lateral rectus recession (bilateral)
First Posted Date
2015-05-21
Last Posted Date
2015-05-21
Lead Sponsor
Samsung Medical Center
Target Recruit Count
60
Registration Number
NCT02450162

Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors

Not Applicable
Completed
Conditions
Refractory Solid Tumors
Interventions
First Posted Date
2015-05-21
Last Posted Date
2017-03-13
Lead Sponsor
Samsung Medical Center
Target Recruit Count
1
Registration Number
NCT02450149
Locations
🇰🇷

Samsung Medical Center, Seoul, seoul, korea, Republic of, Korea, Republic of

Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment

Phase 2
Completed
Conditions
Advanced Gastric Adenocarcinoma
Interventions
First Posted Date
2015-05-20
Last Posted Date
2022-06-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
16
Registration Number
NCT02449551
Locations
🇰🇷

Samsung Medical center, Seoul, Korea, Republic of

The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors

Not Applicable
Completed
Conditions
Solid Tumor
Interventions
First Posted Date
2015-05-20
Last Posted Date
2018-01-17
Lead Sponsor
Samsung Medical Center
Target Recruit Count
5
Registration Number
NCT02449564
Locations
🇰🇷

Samsung Medical center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath